Introduzione

Introduction to Veterinary Pharmacovigilance

Mastery of the regulatory landscape governing veterinary pharmacovigilance stands as a fundamental prerequisite for professionals entering this specialized field. Every individual engaged directly or indirectly in pharmacovigilance operations within any organization must receive appropriate training and demonstrate proficiency in executing their designated responsibilities.

This intensive 8-hour program delivers a thorough foundation in veterinary pharmacovigilance, bridging conceptual knowledge with hands-on application. Rather than offering only theoretical overview, this training prioritizes practical skill development through authentic case studies, interactive exercises, and systematic competency-building activities.

The program's objective is to equip participants with comprehensive theoretical grounding alongside operational proficiency in veterinary pharmacovigilance. Core topics encompass adverse event identification and documentation, pharmacovigilance system master file (PSMF) management, regulatory inspection readiness, integration of pharmacovigilance workflows into quality assurance frameworks, and competence in digital platforms such as Eudra Vet, EVVET, Union Pharmacovigilance Database, and IRIS.

Participants will develop practical capabilities through causality evaluation exercises, VeDDRA terminology workshops, EV Vet system demonstrations, and comprehensive case analyses.

Programme

 

DAY 1: Foundations, Framework & Adverse Event Management
Introduction & Regulatory Landscape

  • What is Veterinary Pharmacovigilance? Importance and scope
  • Key definitions and terminology
  • EU Regulation and UK VMR (Veterinary Medicines Regulations) overview
  • VICH guidelines (GL24, GL35, GL42) – global harmonization
  • Regulatory authorities: EMA, NCAs, VMD roles and responsibilities
  • Marketing Authorization Holder (MAH), QPPV, and EMA/NCA obligations

Adverse Event Identification & Reporting

  • ICSR (Individual Case Safety Report) requirements and standards
  • Types of adverse events: animal, human, environmental, lack of efficacy
  • Regulatory timelines
  • Minimum reporting criteria
  • EVVet system
  • International perspective: CVM (USA), VDD (Canada), APVMA (Australia)

Causality Assessment & Case Evaluation

  • Principles of causality assessment and categories
  • VeDDRA (Veterinary Dictionary for Drug Related Affairs) structure and application
  • Case processing workflow
  • Temporal relationship, dechallenge, rechallenge evaluation
  • Follow-up strategies
  • Documentation requirements and best practices
  • Case Studies

DAY 2: Systems, Compliance & Quality Management
Electronic Systems & Data Management

  • Union Pharmacovigilance Database/EVVet
  • IRIS: adverse event repository management
  • System integration and validation

Pharmacovigilance Infrastructure

  • Pharmacovigilance System Master File (PSMF)
  • Quality Management System (QMS) Integration
  • SOPs for pharmacovigilance activities

Signal Detection & Risk Management

  • Signal detection principles and methodologies
  • Conducting benefit-risk evaluations
  • Statistical concepts for signal identification (basic overview)
  • Prioritization and validation of signals
  • Risk minimization measures and communication strategies
  • Summary reports for regulatory authorities and annual statements
  • Individuals new to veterinary pharmacovigilance seeking comprehensive foundational training
  • Pharmaceutical professionals transitioning to veterinary PV roles
  • Veterinary pharmaceutical professionals planning to undertake QPPV and/or Deputy QPPV roles
  • Support staff needing to understand their role in drug safety operations
  • Quality assurance and regulatory affairs professionals involved in PV activities
  • Veterinaries in industry pharmacovigilance roles
  • Experienced personnel seeking deeper understanding and practical skills in veterinary PV

Participant experience

  • No prior pharmacovigilance experience required
  • Basic understanding of veterinary medicine or pharmaceutical industry is beneficial but not mandatory
  • Participants should have professional interest in drug safety and regulatory compliance

Interactive training including practical session, discussion and Q&A

Docente/i
Camilo Giraldo
Info

Camilo Giraldo

DVM, Former Director of Global Pharmacovigilance – Signal Management, Elanco Animal Health

Camilo Giraldo is a veterinarian with over 30 years of experience in the animal health pharmaceutical industry and is internationally recognized for his leadership in veterinary pharmacovigilance. Based in Switzerland for the past two decades, he has played a key role in shaping global safety systems and advancing scientific standards in signal management.

As Director of Global Pharmacovigilance – Signal Management at Elanco, Camilo led the implementation of a global program that improved the speed and accuracy of safety signal analysis by 40%, ensuring regulatory compliance across multiple regions. His work strengthened global product safety oversight and supported proactive risk mitigation strategies that protect both animal and public health.

Camilo has published and presented internationally on advanced methodologies in pharmacovigilance, including the use of machine learning for signal detection. A frequent speaker and trainer at major regulatory and industry forums, he previously held senior roles at Novartis Animal Health and taught in Veterinary Pharmacology at the University of La Salle, Colombia.


Online Training – 2 modules

Module 1 | 09 April 2026 from 2:00 pm to 6:00 pm CEST
Module 2 | 14 April 2026 from 2:00 pm to 6:00 pm CEST

Some days before the online training you will receive all details about the connection.

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.

Early Bird: € 895,00* (until 19 March 2026)

Ordinary: € 1.095,00*

Freelance – Individual – Academy – Public Administration: € 640,00*

* for Italian companies: +22% VAT

The fee includes: tuitions, organizational office assistance, teaching materials and attendance certificate that will be sent after the training via e-mail.

Versione Stampabile
Cosa saprai fare dopo il corso
Risultato atteso
Understand and apply EU and UK regulatory framework for veterinary pharmacovigilance including key VICH guidelines.
Risultato atteso
Identify, classify, and report adverse events according to regulatory timelines and standards.
Risultato atteso
Perform causality assessments using standardized methodology with complex cases.
Risultato atteso
Code adverse events accurately using VeDDRA terminology in challenging scenarios.
Risultato atteso
Navigate and use EVVet, Union Pharmacovigilance Database, and IRIS for reporting and data management.
Risultato atteso
Process complete adverse event cases from receipt through regulatory submission with appropriate follow-up.
Risultato atteso
Understand PSMF requirements and quality management system integration for pharmacovigilance.
Risultato atteso
Implement signal detection methodologies and conduct benefit-risk evaluations.
Risultato atteso
Establish quality management systems including SOPs and processes ensuring continuous compliance.
Risultato atteso
Build or enhance a pharmacovigilance system with appropriate infrastructure and procedures.

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>

Online interactive training on Zoom platform. 

LS Academy will provide the access link to the virtual platform a few days before the training.

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>